XML 239 R95.htm IDEA: XBRL DOCUMENT v3.10.0.1
Interim Financial Information (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract]                      
Net sales $ 2,572.8 $ 2,478.5 $ 2,694.0 $ 2,784.3 $ 2,586.4 $ 2,416.2 $ 2,389.7 $ 2,407.0 $ 10,529.6 $ 9,799.3 $ 9,071.0
Cost of sales 2,030.0 1,962.9 2,114.8 2,192.5 2,021.6 1,894.6 1,876.8 1,890.7 8,300.2 7,683.7 7,142.3
Gross profit 542.8 515.6 579.2 591.8 564.8 521.6 512.9 516.3 2,229.4 2,115.6 1,928.7
Selling, general and administrative expenses 225.8 230.5 236.0 253.4 240.0 225.0 215.1 219.0 945.7 899.1 818.0
Other expense, net 51.4 7.1 30.4 4.9 117.0 22.0 (0.3) 5.8 93.8 144.5 137.5
Operating income 265.6 278.0 312.8 333.5 207.8 274.6 298.1 291.5 1,189.9 1,072.0 973.2
Equity in affiliates’ earnings, net of tax (10.5) (15.2) (13.0) (10.2) (12.7) (14.4) (14.4) (9.7) (48.9) (51.2) (42.9)
Interest income (2.0) (1.5) (1.4) (1.5) (1.6) (1.3) (1.4) (1.5) (6.4) (5.8) (6.3)
Interest expense and finance charges 13.3 14.4 14.9 16.1 16.9 17.6 18.0 18.0 58.7 70.5 84.6
Other postretirement income (2.0) (2.4) (2.4) (2.6) (1.2) (1.3) (1.4) (1.2) (9.4) (5.1) (4.9)
Earnings before income taxes and noncontrolling interest 266.8 282.7 314.7 331.7 206.4 274.0 297.3 285.9 1,195.9 1,063.6 942.7
Provision for income taxes 19.2 66.8 30.4 94.9 338.4 79.4 76.2 86.3 211.3 580.3 306.0
Net earnings (loss) 247.6 215.9 284.3 236.8 (132.0) 194.6 221.1 199.6 984.6 483.3 636.7
Net earnings attributable to the noncontrolling interest, net of tax 17.6 12.1 12.5 11.7 14.2 9.7 9.1 10.4 53.9 43.4 41.7
Net earnings attributable to BorgWarner Inc. $ 230.0 $ 203.8 $ 271.8 $ 225.1 $ (146.2) $ 184.9 $ 212.0 $ 189.2 $ 930.7 $ 439.9 $ 595.0
Earnings per share — basic $ 1.11 $ 0.98 $ 1.30 $ 1.07 $ (0.70) $ 0.88 $ 1.01 $ 0.89 $ 4.47 $ 2.09 $ 2.78
Earnings per share — diluted $ 1.10 $ 0.98 $ 1.30 $ 1.07 $ (0.70) $ 0.88 $ 1.00 $ 0.89 $ 4.44 $ 2.08 $ 2.76
Restructuring expense $ 22.7 $ 5.7 $ 31.2 $ 7.5 $ 45.2 $ 13.3     $ 67.1 $ 58.5 $ 26.9
Gain on sale of building 19.4               19.4 0.0 0.0
Merger, acquisition and divestiture expense 1.0 1.6 1.0 2.2 3.6 6.4     5.8 10.0 23.7
Asset impairment expense 25.6       71.0       25.6 71.0 127.1
Asbestos-related adjustments 22.8               22.8 0.0 (48.6)
Lease termination settlement               $ 5.3 0.0 5.3 0.0
Tax benefit associated with restructuring (5.5) (1.3) (7.6) (0.6) (8.9) (1.2)     (15.0) (10.1) (6.0)
Effective rate reconciliation, measurement period adjustments due to the Tax Act 7.4 (6.6) (13.4)           (12.6)    
Tax expense on other expense 0.4                    
Effective Income Tax Rate Reconciliation, Deduction, Other, Amount   (0.4)                  
Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount (0.4) (0.5) (21.1)           (22.0)    
Valuation allowance adjustments (9.1)               (10.6) 12.2 (2.7)
Effective income tax rate reconciliation, tax reserve adjustments (2.8)               (2.8)    
Effective Income Tax Rate Reconciliation, Disposition of Asset, Amount 5.8               5.8    
Tax benefit associated with merger and acquisition expense (0.1)     (0.3) (0.7) (0.3)     (0.3) (1.0)  
Tax benefit associated with asset impairment expense (7.7)       (18.2)       (7.7) (18.2)  
Tax impact of other tax adjustments (18.5) (1.8) $ (9.9) 0.4 7.9 $ (5.1) $ (3.2) $ 3.4 (29.8) (3.8) (8.6)
Tax expense on Merger and acquisition   $ 0.1                  
Tax expenses (benefits) associated with asbestos-related adjustments $ (5.5)               (5.5)   17.5
Tax reform adjustments to provision for income taxes         $ 273.5       (12.6) 273.5 0.0
Tax expense on gain from customer contract expiration       0.9         0.9   2.2
Gain on commercial settlement       $ 4.0         $ 4.0 $ 0.0 $ 0.0